France Aesthetic Medicine Market Size
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| Market Size (2024) | USD 506.86 Million |
| Market Size (2029) | USD 841.08 Million |
| CAGR (2024 - 2029) | 10.66 % |
Major Players
*Disclaimer: Major Players sorted in no particular order |
France Aesthetic Medicine Market Analysis
The France Aesthetic Medicine Market size is estimated at USD 506.86 million in 2024, and is expected to reach USD 841.08 million by 2029, growing at a CAGR of 10.66% during the forecast period (2024-2029).
- Due to the high infectivity of the SARS-CoV-2 virus and lockdown regulations by the government, the COVID-19 pandemic led to the cancellation or postponement of cosmetic treatment treatments, which had an effect on the market for aesthetic medicine in France.
- For instance, according to an article published by the American Society of Plastic Surgeons (ASPS) in February 2021, owing to the strict lockdown imposed in the country, the COVID-19 pandemic significantly changed how plastic surgeons practiced throughout the world, including France. Disruptions in the supply chain posed a significant challenge as the demand decreased due to lower customer purchasing power and willingness to buy.
- According to the French Beauty Federation (FEBEA), the French cosmetic industry saw a 10% decline in revenue during the first half of 2020. The consumers' focus shifted from beauty products to hygiene, with hygiene sales increasing by 50% while beauty product sales decreased by 25%. Cosmetic exports in France fell by 14%, while investments decreased by 12%, which are lower than the national averages of 18% and 16%, respectively. Hence, COVID-19 is expected to impact the studied market significantly.
- The aesthetic medicine market in France is expected to grow during the forecast period owing to increasing awareness about cosmetic procedures and the adoption of non- and minimally-invasive aesthetic procedures.
- For instance, according to the 2020 report of the International Society of Aesthetic Plastic Surgery (ISAPS), France was one of the top fifteen countries in the world with the highest number of plastic surgeons in the country performing various cosmetic procedures in the country. Additionally, France is becoming a popular destination for cosmetic surgery, which is anticipated to benefit the aesthetic medicine market.
- For instance, according to an article published in September 2021 titled "What are the Most Performed Cosmetic Surgery Operations in France?" France is one of the major destinations where most buttock enlargement procedures are performed. Also, per the same source, in France, each year, 479 cosmetic surgery procedures are performed for 100,000 people compared to other countries (166 interventions in Japan, 254 in the United Kingdom, and 69 in India). Thus, an increase in cosmetic procedures in France is expected to drive the market in the forecast period.
- However, stringent safety regulations for aesthetic procedures and related adverse effects are expected to restrain France's aesthetic medicine market growth during the forecast period.
France Aesthetic Medicine Market Trends
This section covers the major market trends shaping the France Aesthetic Medicine Market according to our research experts:
Dermal Filler is Expected to Have a Significant Share in the Market Over the Forecast Period
- Dermal fillers are medical device implants used to help create a smoother and/or fuller appearance in the face, including nasolabial folds (the lines extending from the sides of the nose to the edges of the mouth), cheeks, chin, lips, and back of the hands. They are also referred to as injectable implants, soft tissue fillers, lipand facial fillers, and wrinkle fillers.
- Hence, owing to their diverse use in the aesthetics industry, dermal fillers are expected to have a significant share in the French aesthetic medicine market during the forecast period. Numerous surgical and non-surgical reconstructive methods are available to improve oral function, anatomical structures, and aesthetic results to appear more attractive. Dermal fillers are the most used non-surgical procedure to improve the aesthetics and anatomy of the face.
- For instance, according to an article published by Frontiers Media S.A., in August 2021, Hyaluronic acid (HA)-based dermal filler is one of the most used non-surgical regenerative and reconstructive techniques. Its non-immunogenic qualities, which come from its natural occurrence, give it an edge over alternative filler materials. They also play an important role in the aesthetics of the face. Thus, the advantage of dermal fillers over other treatment modalities is expected to drive segmental market growth..
- In addition, the technological advancements in the area and the launch of new products by the companies operating in the region are further expected to boost market growth. For instance, in March 2021, Joonghun Pharmaceutical launched its premium cross-linked hyaluronic acid dermal filler, Artgaon.
- Artgaon, with its certification of the CE mark, specifically targets the European aesthetic market. As per the company, Artgaon's unique cross-linking technology allows doctors to enjoy an injection force of a mere 7-8 newtons that is smooth and consistent. Despite this, Artgaon boasts high elastic (G prime) and cohesive properties inside the skin. Hence, the dermal fillers market is expected to have healthy growth over the forecast period.
Hospitals is Expected to Have a Significant Share in the Market Over the Forecast Period
- The operating unit of the hospital is considered one of the safest and most high-tech surgical units because of the advanced equipment available in the hospitals. The rise in plastic surgeries in France in hospitals and the increase in healthcare expenditure are expected to drive the market's growth.
- For instance, according to data from the Plastic Surgery Societies' Surveys (ISAPS) updated in 2021, the most popular cosmetic surgeries in France in 2020 were Breast Augmentation (53,938 treatments), Liposuction (38,671 procedures), Eyelid Surgery (37,870 procedures), Abdominoplasty (26,888 procedures), and Breast Reduction (21,380 procedures). Thus, the increasing number of plastic surgeries is most likely to drive aesthetic medicine in the country.
- Furthermore, according to the Organization for Economic Co-operation and Development (OECD), healthcare expenditure in France was around USD 304.28 billion in 2021 compared to USD 209.2 billion in 2020. Thus, the increasing healthcare expenditure will likely positively impact the market over the forecast period.
France Aesthetic Medicine Industry Overview
The France aesthetic medicine market is moderate due to the presence of companies operating globally as well as regionally.
The competitive landscape includes an analysis of a few international as well as local companies which hold significant market shares and are well known including AbbVie Inc. (Allergan Plc), Bioxis Pharmaceuticals, Dermaceutic Laboratoire, Ipsen Pharma, Sinclair Pharma PLC, and Johnson & Johnson, among others.
France Aesthetic Medicine Market Leaders
-
AbbVie Inc. (AlLergan Plc)
-
Bioxis Pharmaceuticals
-
Dermaceutic Laboratoire
-
Ipsen Pharma
-
Johnson & Johnson
*Disclaimer: Major Players sorted in no particular order
France Aesthetic Medicine Market News
- January 2022: The European Union's (EU's) Heads of Medicines Agencies (HMA) issued a positive opinion on the approval of Hugel's Letybo, a product containing botulinum toxin (BTX) for the treatment of wrinkles on the forehead.
- June 2021: Galderma announced that Alluzience® completed its European decentralized procedure resulting in a positive decision for the first ready-to-use neuromodulator, a wrinkle relaxing injection, in Europe.
France Aesthetic Medicine Market Report - Table of Contents
1. INTRODUCTION
- 1.1 Study Deliverables and Market Definition
- 1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
- 4.1 Market Overview
-
4.2 Market Drivers
- 4.2.1 Growing Awareness and Adoption of Non- and Minimally-Invasive Aesthetic Procedures
- 4.2.2 Availability of Technologically Advanced & User-friendly Products
-
4.3 Market Restraints
- 4.3.1 Stringent Safety Regulations for Aesthetic Procedures
- 4.3.2 Risk of Side Effects
-
4.4 Porter's Five Forces Analysis
- 4.4.1 Threat of New Entrants
- 4.4.2 Bargaining Power of Buyers/Consumers
- 4.4.3 Bargaining Power of Suppliers
- 4.4.4 Threat of Substitute Products
- 4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value - in USD Millions)
-
5.1 By Product
- 5.1.1 Botulinum Toxin
- 5.1.2 Dermal Filler
- 5.1.2.1 Absorbable Dermal Filler
- 5.1.2.2 Non-absorbable Dermal Filler
- 5.1.3 Chemical Peel
- 5.1.4 Microdermabrasion
- 5.1.5 Other Products
-
5.2 By End User
- 5.2.1 Aesthetic Clinics
- 5.2.2 Hospitals
- 5.2.3 Other End Users
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
- 6.1.1 AbbVie Inc. (AlLergan Plc)
- 6.1.2 Bioxis Pharmaceuticals
- 6.1.3 Dermaceutic Laboratoire
- 6.1.4 Ipsen Pharma
- 6.1.5 Sinclair Pharma PLC
- 6.1.6 Johnson & Johnson
- 6.1.7 Galderma(Nestle Skin Health)
- 6.1.8 Merz Pharma GmbH & Co. KGaA
- 6.1.9 Laboratoires Filorga
- 6.1.10 Teoxane Laboratories
- 6.1.11 Laboratories Vivacy
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
** Subject To AvailablityFrance Aesthetic Medicine Industry Segmentation
Aesthetic medicine is defined as the specialties that focus on enhancing cosmetic appearance through the treatment of aging, infectious, or diseased skin conditions.
The France aesthetic medicine market is segmented by product (botulinum toxin, dermal filler (absorbable dermal filler and non-absorbable dermal filler), chemical peel, microdermabrasion, and other products) and end-user (aesthetic clinics, hospitals, and other end users). The market report also covers the estimated market sizes and trends for France. The report offers the value (in USD million) for the above segments.
| By Product | Botulinum Toxin | |
| Dermal Filler | Absorbable Dermal Filler | |
| Non-absorbable Dermal Filler | ||
| Chemical Peel | ||
| Microdermabrasion | ||
| Other Products | ||
| By End User | Aesthetic Clinics | |
| Hospitals | ||
| Other End Users |
France Aesthetic Medicine Market Research FAQs
How big is the France Aesthetic Medicine Market?
The France Aesthetic Medicine Market size is expected to reach USD 506.86 million in 2024 and grow at a CAGR of 10.66% to reach USD 841.08 million by 2029.
What is the current France Aesthetic Medicine Market size?
In 2024, the France Aesthetic Medicine Market size is expected to reach USD 506.86 million.
Who are the key players in France Aesthetic Medicine Market?
AbbVie Inc. (AlLergan Plc), Bioxis Pharmaceuticals, Dermaceutic Laboratoire, Ipsen Pharma and Johnson & Johnson are the major companies operating in the France Aesthetic Medicine Market.
What years does this France Aesthetic Medicine Market cover, and what was the market size in 2023?
In 2023, the France Aesthetic Medicine Market size was estimated at USD 458.03 million. The report covers the France Aesthetic Medicine Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the France Aesthetic Medicine Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
France Aesthetic Industry Report
Statistics for the 2024 France Aesthetic market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. France Aesthetic analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
